Vascular Biogenics Ltd (VBLT)

[davidal66]

VBLT could run big here without news as well. Biotech is looking more than just fine lately. Take a look at AXON. Coming up on a big binary with a phase III for Alzheimer's which I think does not work, or works in the most tepid fashion. AXON bought there phase III drug from a big pharma for peanuts 5-10 million dollars. Why do I bring up this example? The market cap of AXON is well over 2 billion dollars... for smoke and mirrors. VBLT has ore interesting/innovative tech in a phase III program with a market cap of under 200 million or so. The only difference is the CEO of AXON is beloved on wall street; while Dror is an outsider. For a bet on technology, I would much rather play the biotech roulette table with VBLT than AXON. Sorry to get off topic. But I do get a big disgusted with all of the news reports on AXON; while ignoring the VBLT story; but that could change in a snap.